| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 71,253 | 58,083 | 50,129 | 58,352 | | Cost of Revenue | 48,790 | 44,574 | 34,535 | 41,756 | | | Gross Profit | 22,463 | 13,509 | 15,594 | 16,596 | | | Operating Expenses | | Research Development | 10,583 | 11,250 | 11,414 | 13,860 | | Selling General and Administrative | 10,399 | 9,802 | 10,449 | 13,501 | | Non Recurring | 485 |
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,481 | (7,543) | (6,269) | (10,765) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,861 | 203 | 497 | (30,022) | | Earnings Before Interest And Taxes | 5,342 | (7,340) | (5,772) | (31,642) | | Interest Expense |
-
|
-
|
-
| 140 | | Income Before Tax | 5,342 | (7,340) | (5,772) | (31,782) | | Income Tax Expense | 1,643 | (1,146) | 2,874 | 1,740 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,577 | (6,448) | (9,241) | (36,627) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,092 | (6,448) | (9,241) | (36,627) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,092 | ($6,448) | ($9,241) | ($36,627) |
|
0.11% Nasdaq 
0.01%
Income Statement
